Cost-effectiveness and population outcomes of general population screening for hepatitis C.
Clin. Infect. Dis., May;54(9):1259-71 (2012)
Risk factors for nonfatal overdose at Seattle-area syringe exchanges.
J Urban Health., Feb;88(1):118-28 (2011)
Patient acceptance of universal screening for hepatitis C virus infection.
BMC Infect. Dis., 11:160 (2011)
Prevalence and characteristics of femoral injection among Seattle-area injection drug users.
J Urban Health., Apr;89(2):365-72 (2012)